CDK5 and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease models, for instance, hyperactivated Cdk5 excessively phosphorylates the protein Tau, leading directly to synaptic damage and cognitive decline, highlighting the critical importance of maintaining a fine balance of Cdk5 activity [64].